Limited EvidencePolyphenol / Antihypertensive Botanical4 Products Compared

Best Olive Leaf Extract Supplements for Cardiovascular Health in 2026

Reviewed by Angelique Nicole R. Villegas, RND, Registered Nutritionist Dietitian · PRC Philippines · License #0023950

Updated Invalid Date

In 2011, a randomized controlled trial published in the journal Phytomedicine compared olive leaf extract to captopril — a commonly prescribed ACE inhibitor antihypertensive medication — in patients with stage-1 hypertension. After 8 weeks, both groups achieved statistically equivalent reductions in systolic and diastolic blood pressure (Susalit et al., PMID 21036583). This is an extraordinary finding in the supplement literature: a botanical extract matching a pharmaceutical drug in a head-to-head RCT on the primary endpoint. The mechanism is well understood. Oleuropein — the primary polyphenol in olive leaf — inhibits angiotensin-converting enzyme (ACE) activity, the same target as the ACE inhibitor drug class (captopril, lisinopril, ramipril). Oleacein, a second secoiridoid polyphenol in olive leaf, appears to exert complementary calcium channel modulation, adding a second blood pressure mechanism. Together, these compounds explain OLE's antihypertensive action through pathways that are pharmacologically coherent. Critical caveat: this finding does not mean olive leaf extract should replace prescribed antihypertensive medications. The Susalit study enrolled patients with stage-1 hypertension who were not yet on medication — it was not an add-on or substitution trial in treated hypertensives. Individuals on ACE inhibitors must be aware of potential additive interactions. This evidence positions OLE as a credible evidence-based option for borderline or early-stage blood pressure elevation, under physician awareness.

This content is for educational purposes only and is not medical advice. These statements have not been evaluated by the FDA. Always consult your healthcare provider before starting any supplement.

Why It Works

Key Benefits of Olive Leaf Extract for Cardiovascular Health

Our Picks

Best Olive Leaf Extract for Cardiovascular Health in 2026

Ranked by quality, value, and clinical backing

Where available, we show when each product price was last checked so the list stays honest without overreacting to normal Amazon price movement.

Side-by-Side

Comparison Table

The Science

How Olive Leaf Extract Supports Cardiovascular Health

Buying Guide

What to Look For When Buying Olive Leaf Extract

Dosage

Dosage Guidance

Always follow your healthcare provider's recommendations. Dosages vary by individual health status, age, and goals.

What Users Complain About

Common Olive Leaf Extract Complaints (And How to Avoid Them)

Based on analysis of thousands of customer reviews across Olive Leaf Extract products.

"I'm already on a blood pressure medication — can I add OLE?"

This requires physician guidance before acting. OLE has demonstrated ACE-inhibitory activity through the same mechanism as ACE inhibitor medications (lisinopril, captopril, ramipril). Adding OLE to an existing ACE inhibitor could produce additive blood pressure reduction and risk symptomatic hypotension. Your physician can assess your current BP control, medication dose, and whether OLE could complement or require adjustment of your current regimen. Do not self-add OLE to a pharmaceutical antihypertensive regimen without that discussion.

"How is olive leaf extract different from olive oil for heart health?"

Olive oil's cardiovascular benefit is attributed primarily to oleic acid (a monounsaturated fat) and some polyphenols present in extra-virgin grades. Olive leaf extract provides a highly concentrated form of the leaf polyphenols — oleuropein and oleacein — at doses many times higher than what is present in olive oil or dietary olive consumption. The ACE-inhibitory and calcium channel-modulating effects documented in OLE RCTs are not achievable through olive oil consumption at realistic dietary quantities. OLE is mechanistically distinct from olive oil supplementation.

"The RCT used a specific branded extract. Does this apply to my OLE product?"

This is a legitimate concern. The Susalit 2011 RCT used EFLA943, a specific high-standardization OLE extract with ~17% oleuropein. Not all commercial OLE products match this standardization level. To select a product that reasonably approximates the RCT formulation, look for: standardized oleuropein content (target 15–20%), total extract dose of 500–1,000mg/day, and clear quality certification (GMP, third-party testing). Products with stated oleuropein percentages and credible quality marks are more likely to deliver relevant OPC levels.

Safety

Safety & Interactions

CRITICAL DRUG INTERACTION — ACE INHIBITORS: Olive leaf extract has documented ACE-inhibitory activity. If you are currently taking ACE inhibitor medications (including lisinopril, ramipril, enalapril, captopril, perindopril, benazepril), consult your physician before using OLE. Additive blood pressure reduction is possible and may cause blood pressure to drop below safe levels (hypotension). This interaction is pharmacologically plausible and clinically significant. Blood pressure monitoring: Individuals using OLE for blood pressure support should monitor blood pressure regularly and inform their physician. Diabetes medication: Wainstein 2012 found glucose-lowering effects in diabetic patients. If you take insulin or oral hypoglycemics, monitor blood glucose with physician awareness when starting OLE. General tolerability: OLE is well-tolerated in studies. Occasional gastrointestinal discomfort (nausea, stomach upset) has been reported. Take with food to minimize GI effects. Pregnancy and breastfeeding: Insufficient safety data. Avoid supplemental OLE during pregnancy and breastfeeding. Always consult your healthcare provider before beginning any new supplement, particularly if you have cardiovascular disease, diabetes, or are taking any medications.

"
"The Susalit 2011 captopril comparison is the most compelling single data point in the OLE evidence base — and arguably in the entire blood pressure supplement literature. A head-to-head comparison with a pharmaceutical antihypertensive showing equivalent primary endpoint results is exceptionally rare in the dietary supplement world. The critical nuance: the comparison was in untreated stage-1 hypertension, the OLE formulation was a specific high-standardization extract (EFLA943, ~17% oleuropein), and the captopril dose was not at maximum therapeutic intensity. Nonetheless, the mechanistic coherence (OLE's ACE inhibition via oleuropein + calcium channel modulation via oleacein, matching the class mechanism of captopril) makes this more than a statistical accident. OLE deserves serious clinical attention for mild-to-moderate hypertension management discussions."
— Angelique Nicole R. Villegas, RND, Registered Nutritionist Dietitian · PRC Philippines · License #0023950

Common Questions

Frequently Asked Questions

Olive leaf extract's primary blood pressure mechanism is ACE inhibition. Oleuropein — the main polyphenol in olive leaf — inhibits angiotensin-converting enzyme (ACE), which normally converts angiotensin I to angiotensin II (a potent vasoconstrictor). By inhibiting ACE, oleuropein reduces angiotensin II production, decreasing vascular resistance and lowering blood pressure. This is the same mechanism as the ACE inhibitor drug class (captopril, lisinopril, ramipril). Oleacein, a second OLE polyphenol, may additionally modulate calcium channels in vascular smooth muscle — providing a complementary vasodilation pathway.

Not without physician guidance. OLE has documented ACE-inhibitory activity through the same mechanism as ACE inhibitor drugs. Combining OLE with a pharmaceutical ACE inhibitor could produce additive blood pressure reduction and risk hypotension (blood pressure dropping too low). If you take lisinopril, ramipril, enalapril, captopril, or other ACE inhibitors, discuss OLE with your physician before starting. This is one of the most important drug interactions to be aware of in this category.

The Susalit 2011 RCT used an extract standardized to approximately 17% oleuropein at a dose of 500mg twice daily (totaling ~170mg oleuropein/day). For clinical relevance, look for products with at least 10–20% oleuropein standardization. Products listing only total extract weight without oleuropein percentage provide no quality guarantee on active compound content. The stated oleuropein percentage is the most important quality variable to check on the label.

The Susalit 2011 RCT showed significant blood pressure reduction over 8 weeks of supplementation. Most OLE blood pressure studies assess outcomes at 6–12 weeks. Olive leaf extract is not an acute intervention — its ACE-inhibitory effects develop over weeks of consistent use, not hours. Regular monitoring of blood pressure (every 2–4 weeks) is recommended when beginning OLE supplementation under physician awareness.

A secondary finding from the Susalit 2011 RCT was that the OLE group showed a reduction in LDL cholesterol that was not seen in the captopril group — suggesting a cholesterol-lowering effect independent of the blood pressure mechanism. This is consistent with oleuropein's antioxidant properties (reducing LDL oxidation) and its known effects on hepatic cholesterol synthesis pathways. However, the primary and most robust evidence for OLE is on blood pressure, not cholesterol, and it should not be positioned as a primary cholesterol intervention.

Scientific References

Citations & Research

This page references peer-reviewed research indexed on PubMed/NCBI. Citations are provided for transparency. Always consult a qualified healthcare professional before making any medical decisions.

Ready to Try Olive Leaf Extract?

Our top pick for cardiovascular health. Third-party tested, highly reviewed.

Shop #1 Pick — NOW Foods Olive Leaf Extract 500mg

Affiliate link — we may earn a commission at no extra cost to you